Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N0259108904
Study information
Scientific title
Acronym
Study hypothesis
Erythromycin's effect on gastric emptying in intensive care.
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Hospitals
Trial type
Treatment
Patient information sheet
Condition
Signs and Symptoms:
Intervention
Nasogastric erythromycin compared to intravenous erythromycin
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measure
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/01/2002
Overall trial end date
01/07/2004
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
Patients who exhibit a failure to absorb nasogastric feed
Participant type
Patient
Age group
Adult
Gender
Not Specified
Target number of participants
20
Participant exclusion criteria
Not provided at time of registration
Recruitment start date
01/01/2002
Recruitment end date
01/07/2004
Locations
Countries of recruitment
United Kingdom
Trial participating centre
The Walton Centre for Neurology & Neurosurgery
Liverpool
L9 7LJ
United Kingdom
Sponsor information
Organisation
Department of Health (UK)
Sponsor details
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Sponsor type
Government
Website
Funders
Funder type
Government
Funder name
The Walton Centre for Neurology and Neurosurgery NHS Trust (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list